of 3-Aminophenol in B6D2F1 Mice

Similar documents
Summary of Feed Carcinogenicity Study. of Diphenylamine. in F344 Rats

Summary of Inhalation Carcinogenicity Study. of Isopropyl Acetate. in F344 Rats

Summary of Inhalation Carcinogenicity Study. of Tetrachloroethylene. in BDF 1 Mice

Glyphosate Cancer Risks and Failures of the Pesticide Regulatory Process

Spontaneous Neoplasms and Survival in Wistar Han Rats: Compilation of Control Group Data. March, 2003

Aspartame: the experimental evidence of cancer risks

Spontaneous Neoplastic Lesions in the CrI:CD-1(ICR) Mouse in Control Groups from 18 Month to 2 year Studies. March, 2005

Carcinogenicity Test of 2-Ethoxy-2-methylpropane in Rats (Inhalation Study)

Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse. March, 2000

THE EFFECT OF DIFFERENT TUMOR GROUPINGS ON FINDINGS OF ANTICARCINOGENIC RESPONSES IN LONG-TERM RODENT BIOASSAYS. Harvard University

TUMORS OF SPRAGUE-DAWLEY RATS INDUCED BY LONG-TERM FEEDING OF PHENACETIN*1

Table of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3

Spontaneous Neoplastic Lesions in the CrI:CD-I (ICR)BR Mouse. March, 2000

Spontaneous Neoplastic Lesions in Aged Sprague-Dawley Rats

Aspartame induces lymphomas and leukaemias in rats Aspartame, a leukaemogenic compound

Icd 10 code metastatic adenocarcinoma endometrial

Practical approaches for endocrine toxicity in preclinical safety assessment

Study of the main chemical components of Ganoderma lucidum

Study of the main chemical components of Ganoderma lucidum

Tumorigenicity Study of Sodium Erythorbate Administered Orally to Mice

SHN-1 Human Digestive Panel Test results

The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment

FENPYROXIMATE (addendum) First draft prepared by T.C. Marrs Food Standards Agency, London, England. Explanation

SCIENTIFIC OPINION. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (EFSA-Q ) Adopted on 19 March 2009

Neoplasia literally means "new growth.

Folpet (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief

3. Studies of Cancer in Experimental Animals

uterine cancer endometrial cancer

5.15 HEXYTHIAZOX (176)

DOWNLOAD ENTIRE DOCUMENT FROM

Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

List of Available TMAs in the PRN

chronic toxicity studies on white oils

Case 3:16-md VC Document Filed 10/28/17 Page 1 of 38 EXHIBIT 96

Yours sincerely, C. Guilhem de Seze EFSA Head of Department of Scientific Evaluation of Regulated Products. de Bruijn ECHA Director of Risk Management

Endometrial adenocarcinoma icd 10 code

EU assessment of the carcinogenic potential of glyphosate

NEOPLASIA-I CANCER. Nam Deuk Kim, Ph.D.

SCOPE OF PRACTICE PGY-5

Lung cancer pleural invasion was recognized as a poor prognostic

(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017)

Mammary Nodular Hyperplasia in Intact R hesus Monkeys

The carcinogenicity of benzene. The IARC Monograph Vol 120. Kurt Straif, MD MPH PhD. PSA, Stavanger, 25 October 2018

Lách

OECD/OCDE 407 Adopted: 3 October 2008 OECD GUIDELINES FOR THE TESTING OF CHEMICALS

Supplementary Figure 1. Genotyping strategies for Mcm3 +/+, Mcm3 +/Lox and Mcm3 +/- mice and luciferase activity in Mcm3 +/Lox mice. A.

COMMITTEE ON CARCINOGENICITY OF CHEMICALS IN FOOD, CONSUMER PRODUCTS AND THE ENVIRONMENT

BIOASSAY OF FLUOMETURON

5. Summary of Data Reported and Evaluation

5.17 PENTHIOPYRAD (253)

Endometrial adenocarcinoma icd 10 code

TR-469 Toxicology and Carcinogenesis Studies of AZT (CAS No ) and AZT/-Interferon A/D B6C3F1 Mice (Gavage Studies)

Icd-10 code for small cell lung cancer

FLONICAMID. First draft prepared by K. Low 1 and C. Lambré 2. Ontario, Canada

Case: The patient is a 73 year old woman with vague complaints of dyspepsia and abdominal pain. Upper endoscopy showed features of gastritis and a

The Effect of Different Tumor Groupings on Findings of Anticarcinogenic Responses in Long-Term Rodent Bioassays

Abdulrahman Alhanbali. Bahaa Najjar. Maha shomaf

IMPC phenotyping SOPs in JMC

Captan (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief

Evaluation of Ramazzini Institute Aspartame Studies and EFSA s Assessment

Atypical Hyperplasia/EIN

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens

CODING TUMOUR MORPHOLOGY. Otto Visser

Proceeding of the SEVC Southern European Veterinary Conference

NUMBER: The purpose of this policy is to provide guidelines for mice and rats involved in tumor studies.

ORIGIN OF PULMONARY TUMORS IN RATS INDUCED BY 4-NITROQUINOLINE 1-OXIDE. (Plates I-V)

Supplemental Table 1. Effect of Testosterone Treatment on Organ Weight in Mice (% of body weight, mean ± SD).

number Done by Corrected by Doctor مها شوماف

Increasing Trend in the Incidence of Colorectal Cancer in Japan

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

Summary of Toxicity Studies on Imazapyr

3. Studies of Cancer in Experimental Animals

Interim Specific Ground Water Criterion o, m, p-cresol. Alan H. Stern, Dr.P.H., D.A.B.T. Office of Science NJDEP 2/25/10

SCREENING-LEVEL HAZARD CHARACTERIZATION Monocyclic Aromatic Amines Category. Sponsored Chemicals

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

FINALIZED SEER SINQ QUESTIONS January June, 2016

Stromal Fat Content of the Parathyroid Gland

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

International Safety Assessment of Sweeteners

A Canine Case of Complex Carcinoma of the Mammary Gland with Metastasis to the Axillary Lymph Node

Consequences of Exposure to Carcinogens Beginning During Developmental Life

5.36 THIOPHANATE-METHYL (077)

UTERINE LESIONS ASSOCIATED WITH FIBROMYOMA*

SUPPLEMENTARY FIGURE LEGENDS

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH

Abstract. Anb Med J Vol.11 No.1; 62-68

Disorders of Cell Growth & Neoplasia. Histopathology Lab

Classification of Neoplasms

FORUM Spontaneous Neoplasms in Control Wistar Rats: A Comparison of Reviews

Conflict of Interest Statement

Status of Activities on BPA

To: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004

TUMOR,NEOPLASM. Pathology Department, Zhejiang University School of Medicine,

FLUENSULFONE. First draft prepared by Ian Dewhurst 1 and Maria Tasheva 2. Chemicals Regulation Directorate, York, England, United Kingdom

Supplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

incidence rate x 100,000/year

Metastatic pancreatic cancer, icd-10

Pancreatobiliary Frozen Section Nightmares

Transcription:

Summary of Drinking Water Carcinogenicity Study of 3-Aminophenol in B6D2F1 Mice July 2012 Japan Bioassay Research Center Japan Industrial Safety and Health Association

PREFACE The tests were contracted and supported by the Ministry of Health, Labour and Welfare of Japan. The tests were conducted by Japan Bioassay Research Center (JBRC) and the report was prepared by JBRC and peer reviewed by outside expert pathologist. Complete report was submitted to Ministry of Health, Labour and Welfare of Japan on July 31, 2012. This English Summary was translated by JBRC from Japanese complete report.

(Study No.0712) Summary of Drinking Water Carcinogenicity Study of 3-Aminophenol in B6D2F1 Mice Purpose, materials and methods 3-Aminophenol (CAS No. 591-27-5) is a white to pale gray crystals and with a melting point of 122 C. It is soluble in water, alcohol, and ether. The carcinogenicity and chronic toxicity of 3-aminophenol were examined in B6D2F1/Crlj mice. Groups of test animals were administered 3-aminophenol in their drinking water for 2 years (104 weeks). Each group consisted of either 50 male or 50 female mice. The drinking water concentration of 3-aminophenol were 0, 625, 1250 or 2500 ppm (w/w). Both sexes were administered each concentration of 3-aminophenol. The highest dose level was chosen so as not to exceed the maximum tolerated dose (MTD), based on both growth rate and toxicity in a previous 13-week toxicity study. The identity of the 3-aminophenol used in these experiments was confirmed by both infrared spectrometry and mass spectrometry. The chemical was analyzed by high performance liquid chromatography before and after use to affirm its stability. The concentrations of 3-aminophenol in the drinking water were determined by high performance liquid chromatography at the time of preparation and on the 4th day after preparation while stored at room temperature. The animals were observed daily for clinical signs and mortality. Body weight, water consumption and food consumption were measured once a week for the first 14 weeks and every 4 weeks thereafter. Animals found dead, in a moribund state, or surviving to the end of the 2-year administration period underwent complete necropsy. Urinalysis was performed near the end of the administration period. Hematology and blood biochemistry analysis were performed at the terminal necropsy: surviving animals were fasted overnight and bled under anesthesia. Organs and tissues were removed, weighed and examined for macroscopic lesions at necropsy. The organs and tissues were then fixed and embedded in paraffin. Three μm thick tissue sections were prepared and stained with hematoxylin and eosin and examined microscopically. Incidences of neoplastic lesions were statistically analyzed by Fisher s exact test. Any positive dose-response trends of 3-aminophenol induction of neoplastic lesions were analyzed by Peto s test. Incidences of non-neoplastic lesions and urinalysis were analyzed by the Chi-square test. Changes in body weight, water consumption, food consumption, hematological and blood biochemical parameters, and organ weights were analyzed by Dunnett s test. The present studies were conducted in accordance with the Organisation for Economic Co-operation and Development (OECD) Good Laboratory 1

(Study No.0712) Practice and with reference to the OECD Guideline for Testing of Chemicals 451 Carcinogenicity Studies. Results No significant differences in survival rates were found between any of the groups administered 3-aminophenol and their respective controls. Brown urine was observed in the males and females administered 1250 ppm and above. Body weights were supressed in the males and females administered 2500 ppm throughout the 2-year administration period, and body weights were supressed in the males administered 1250 ppm in the middle of administration period. Body weights were also supressed in the females administered 1250 ppm sporadically. Food consumption was decreased in the males administered 2500 ppm throughout the 2-year administration period, food consumption was decreased in the females administered 1250 ppm and above sporadically. Water consumption of males and females administered 2500 ppm were suppressed throughout the 2-year administration period. Water consumption was decreased in the males and females administered 1250 ppm and females administered 625 ppm in many of the 2-year administration period. The incidences of selected neoplastic lesions in male and female mice are presented in the tables below. No significant increase in the incidence of neoplastic or neoplasm related lesions was found in any 3-aminophenol-administered group of either sex as compared with the respective control. In blood and hematopoietic system, methemoglobin concentration was increased in the males and females administered 2500 ppm 3-aminophenol. Red blood cell count and hemoglobin concentration was decreased in females administered 2500 ppm. Mean corpuscular volume was increased in males administered 1250 ppm and above. Mean corpuscular hemoglobin was increased in males administered 2500 ppm. Mean corpuscular hemoglobin concentration was decreased in females administered 1250 ppm and above. Reticulocyte was increased in males administered 2500 ppm and females administered 1250 ppm and above. In the spleen, deposit of hemosiderin was incresed in males and females administered 1250 ppm and above. Increased extramedullary hematopoiesis was significantly observed in males and females administered 2500 ppm. Deposit of brown pigment was increased also in liver and follicular cell in thyroid in males and females administered 2500 ppm. Using blood and hematopoietic system as endpoint markers, the no-observed-adverse-effectlevel (NOAEL) of 3-aminophenol in the drinking water was 625 ppm (64 mg/kg body weight per day for male and 81 mg/kg body weight per day for female). 2

(Study No.0712) Conclusions There was no evidence for carcinogenicity of 3-aminophenol in male and female mice. 3

(Study No. 0712) Incidences of selected neoplastic lesions of male mice in the 2-year drinking water carcinogenicity study of 3-aminophenol Dose (ppm) 0 625 1250 2500 Peto test Cochran- Armitage test Number of examined animals 50 50 50 50 benign tumor lung bronchiolar-alveolar adenoma 6 2 3 6 spleen hemangioma 1 3 1 1 liver hemangioma 2 3 3 1 hepatocellular adenoma 16 8 9 1 ** Harderian gland adenoma 2 3 4 0 malignant tumor lung bronchiolar-alveolar carcinoma 10 9 2 * 3 * lymph node malignant lymphoma 7 4 9 6 liver histiocytic sarcoma 6 2 4 1 hepatocellular carcinoma 7 6 5 2 lung bronchiolar-alveolar adenoma + bronchiolar-alveolar carcinoma liver hepatocellular adenoma + hepatocellular carcinoma 16 10 5 ** 9 21 13 12 * 3 ** Significant difference *: p 0.05 **: p 0.01 (Fisher test) : p 0.05 increase : p 0.01 increase (Peto, Cochran-Armitage test) : p 0.05 decrease : p 0.01 decrease (Cochran-Armitage test) 4

(Study No. 0712) Incidences of selected neoplastic lesions of female mice in the 2-year drinking water carcinogenicity study of 3-aminophenol Dose (ppm) 0 625 1250 2500 Peto test Cochran- Armitage test Number of examined animals 50 50 50 50 benign tumor lung bronchiolar-alveolar 2 3 1 1 adenoma liver hemangioma 1 1 1 3 hepatocellular adenoma 4 6 4 5 pituitary adenoma 4 9 6 7 ovary papillary adenoma 1 0 4 1 uterus endometrial stromal polyp 3 2 2 2 Harderian gland adenoma 1 0 4 3 malignant tumor lung bronchiolar-alveolar 1 4 1 2 carcinoma lymph node malignant lymphoma 18 17 21 10 liver histiocytic sarcoma 2 3 0 1 ovary histiocytic sarcoma 16 14 12 12 a mammary adenocarcinoma 0 1 0 3 gland adenosquamous carcinoma 0 1 0 1 mammary adenocarcinoma+ gland 0 2 0 4 adenosquamous carcinoma a :Significant only in Prevalence method in Peto test. Significant difference *: p 0.05 **: p 0.01 (Fisher test) : p 0.05 increase : p 0.01 increase (Peto, Cochran-Armitage test) : p 0.05 decrease : p 0.01 decrease (Cochran-Armitage test) 5

(Study No. 0712) SELECTED TABLES TABLE C 1 BODY WEIGHT CHANGES AND SURVIVAL ANIMAL NUMBERS: MALE TABLE C 2 BODY WEIGHT CHANGES AND SURVIVAL ANIMAL NUMBERS: FEMALE TABLE C 3 TABLE C 4 BODY WEIGHT CHANGES: MALE BODY WEIGHT CHANGES: FEMALE TABLE D 1 FOOD CONSUMPTION CHANGES AND SURVIVAL ANIMAL NUMBERS: MALE TABLE D 2 FOOD CONSUMPTION CHANGES AND SURVIVAL ANIMAL NUMBERS: FEMALE TABLE D 3 TABLE D 4 FOOD CONSUMPTION CHANGES: MALE FOOD CONSUMPTION CHANGES: FEMALE TABLE E 1 WATER CONSUMPTION CHANGES AND SURVIVAL ANIMAL NUMBERS: MALE TABLE E 2 WATER CONSUMPTION CHANGES AND SURVIVAL ANIMAL NUMBERS: FEMALE TABLE E 3 TABLE E 4 WATER CONSUMPTION CHANGES: MALE WATER CONSUMPTION CHANGES: FEMALE TABLE F 1 TABLE F 2 CHEMICAL INTAKE CHANGES: MALE CHEMICAL INTAKE CHANGES: FEMALE TABLE G 1 TABLE G 2 HEMATOLOGY: MALE HEMATOLOGY: FEMALE TABLE H 1 TABLE H 2 BIOCHEMISTRY: MALE BIOCHEMISTRY: FEMALE 6

(Study No. 0712) SELECTED TABLES (CONTINUED) TABLE I 1 TABLE I 2 URINALYSIS: MALE URINALYSIS: FEMALE TABLE K 1 TABLE K 2 ORGAN WEIGHT, ABSOLUTE: MALE ORGAN WEIGHT, ABSOLUTE: FEMALE TABLE L 1 TABLE L 2 ORGAN WEIGHT, RELATIVE: MALE ORGAN WEIGHT, RELATIVE: FEMALE TABLE M 1 HISTOPATHOLOGICAL FINDINGS: NON-NEOPLASTIC LESIONS: MALE: ALL ANIMALS TABLE M 4 HISTOPATHOLOGICAL FINDINGS: NON-NEOPLASTIC LESIONS: FEMALE: ALL ANIMALS TABLE P 1 TABLE P 2 NEOPLASTIC LESIONS-INCIDENCE AND STATISTICAL ANALYSIS: MALE NEOPLASTIC LESIONS-INCIDENCE AND STATISTICAL ANALYSIS: FEMALE TABLE R HISTORICAL CONTROL DATA OF SELECTED NEOPLASTIC LESIONS IN JAPAN BIOASSAY RESEARCH CENTER: B6D2F1/Crlj FEMALE MICE TABLE S 1 TABLE S 2 CAUSE OF DEATH: MALE CAUSE OF DEATH: FEMALE 7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

(Study No. 0712) FIGURES FIGURE 1 SURVIVAL ANIMAL RATE OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 2 SURVIVAL ANIMAL RATE OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 3 BODY WEIGHT CHANGES OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 4 BODY WEIGHT CHANGES OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 5 FOOD CONSUMPTION CHANGES OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 6 FOOD CONSUMPTION CHANGES OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 7 WATER CONSUMPTION CHANGES OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 8 WATER CONSUMPTION CHANGES OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL 162

(Study No. 0712) FIGURE 1 SURVIVAL ANIMAL RATE OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 2 SURVIVAL ANIMAL RATE OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL 163

(Study No. 0712) FIGURE 3 BODY WEIGHT CHANGES OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 4 BODY WEIGHT CHANGES OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL 164

(Study No. 0712) FIGURE 5 FOOD CONSUMPTION CHANGES OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 6 FOOD CONSUMPTION CHANGES OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL 165

(Study No. 0712) FIGURE 7 WATER CONSUMPTION CHANGES OF MALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL FIGURE 8 WATER CONSUMPTION CHANGES OF FEMALE MICE IN THE 2-YEAR DRINKING WATER STUDY OF 3-AMINOPHENOL 166

167